(Updated - July 10, 2025 6:23 AM EDT)

Goldman Sachs analyst Corinne Johnson resumes coverage on ArriVent BioPharma (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE